Noven Announces Final FDA Approval of Stavzor™ for the Treatment of Bipolar Disorder, Seizures and Migraine Headaches

PhotoPhoto

Back to: News Release
Stavzor(TM) (valproic acid delayed release capsules) (Photo: Business Wire)
Stavzor(TM) (valproic acid delayed release capsules) (Photo: Business Wire)

Download Formats

Share This Photo

URL:

Smart Multimedia Gallery

Stavzor(TM) (valproic acid delayed release capsules) (Photo: Business Wire)
Stavzor(TM) (valproic acid delayed release capsules) (Photo: Business Wire)Photo

Stavzor(TM) (valproic acid delayed release capsules) (Photo: Business Wire)

http://www.businesswire.com/multimedia/google/20080730005608/en/1659279
http://www.businesswire.com/multimedia/google/20080730005608/en/1659279Logo

Download Formats

More
http://www.businesswire.com/multimedia/google/20080730005608/en/1659280
http://www.businesswire.com/multimedia/google/20080730005608/en/1659280Logo

Download Formats

More

Better Be Business Wired.

Business Wire is the leading source for press releases, photos, multimedia and regulatory filings from companies and groups throughout the world.